144 related articles for article (PubMed ID: 30849523)
1. Kinetics mechanism and regulation of native human hepatic thymidine phosphorylase.
Oh T; El Kouni MH
Int J Biochem Cell Biol; 2019 May; 110():122-129. PubMed ID: 30849523
[TBL] [Abstract][Full Text] [Related]
2. Kinetic studies of thymidine phosphorylase from mouse liver.
Iltzsch MH; el Kouni MH; Cha S
Biochemistry; 1985 Nov; 24(24):6799-807. PubMed ID: 4074727
[TBL] [Abstract][Full Text] [Related]
3. 2-Deoxy-D-ribose, a downstream mediator of thymidine phosphorylase, regulates tumor angiogenesis and progression.
Nakajima Y; Madhyastha R; Maruyama M
Anticancer Agents Med Chem; 2009 Feb; 9(2):239-45. PubMed ID: 19199868
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of metastasis of tumor cells overexpressing thymidine phosphorylase by 2-deoxy-L-ribose.
Nakajima Y; Gotanda T; Uchimiya H; Furukawa T; Haraguchi M; Ikeda R; Sumizawa T; Yoshida H; Akiyama S
Cancer Res; 2004 Mar; 64(5):1794-801. PubMed ID: 14996742
[TBL] [Abstract][Full Text] [Related]
5. Suppression of thymidine phosphorylase-mediated angiogenesis and tumor growth by 2-deoxy-L-ribose.
Uchimiya H; Furukawa T; Okamoto M; Nakajima Y; Matsushita S; Ikeda R; Gotanda T; Haraguchi M; Sumizawa T; Ono M; Kuwano M; Kanzaki T; Akiyama S
Cancer Res; 2002 May; 62(10):2834-9. PubMed ID: 12019161
[TBL] [Abstract][Full Text] [Related]
6. The kinetic mechanism of Human Thymidine Phosphorylase - a molecular target for cancer drug development.
Deves C; Rostirolla DC; Martinelli LK; Bizarro CV; Santos DS; Basso LA
Mol Biosyst; 2014 Mar; 10(3):592-604. PubMed ID: 24407036
[TBL] [Abstract][Full Text] [Related]
7. Distinct substrate specificity and physicochemical characterization of native human hepatic thymidine phosphorylase.
Oh T; El Kouni MH
PLoS One; 2018; 13(8):e0202826. PubMed ID: 30138393
[TBL] [Abstract][Full Text] [Related]
8. 2-Deoxy-L-ribose inhibits the invasion of thymidine phosphorylase-overexpressing tumors by suppressing matrix metalloproteinase-9.
Nakajima Y; Haraguchi M; Furukawa T; Yamamoto M; Nakanishi H; Tatematsu M; Akiyama S
Int J Cancer; 2006 Oct; 119(7):1710-6. PubMed ID: 16646076
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in the synthetic thymidine phosphorylase inhibitors for cancer therapy.
Feng Q; Yang W; Peng Z; Wang G
Eur J Pharmacol; 2022 Nov; 934():175319. PubMed ID: 36220359
[TBL] [Abstract][Full Text] [Related]
10. The role of phosphate in the action of thymidine phosphorylase inhibitors: Implications for the catalytic mechanism.
Jain HV; Rasheed R; Kalman TI
Bioorg Med Chem Lett; 2010 Mar; 20(5):1648-51. PubMed ID: 20138520
[TBL] [Abstract][Full Text] [Related]
11. Thymidine phosphorylase influences [(18)F]fluorothymidine uptake in cancer cells and patients with non-small cell lung cancer.
Lee SJ; Yeo JS; Lee HJ; Lee EJ; Kim SY; Jang SJ; Lee JJ; Ryu JS; Moon DH
Eur J Nucl Med Mol Imaging; 2014 Jul; 41(7):1327-35. PubMed ID: 24562648
[TBL] [Abstract][Full Text] [Related]
12. Differences in activities and substrate specificity of human and murine pyrimidine nucleoside phosphorylases: implications for chemotherapy with 5-fluoropyrimidines.
el Kouni MH; el Kouni MM; Naguib FN
Cancer Res; 1993 Aug; 53(16):3687-93. PubMed ID: 8339277
[TBL] [Abstract][Full Text] [Related]
13. Kinetic parameters and recognition of thymidine analogues with varying functional groups by thymidine phosphorylase.
Hatano A; Harano A; Takigawa Y; Naramoto Y; Toda K; Nakagomi Y; Yamada H
Bioorg Med Chem; 2008 Apr; 16(7):3866-70. PubMed ID: 18272369
[TBL] [Abstract][Full Text] [Related]
14. Rapid disappearance of deoxyribose-1-phosphate in platelet derived endothelial cell growth factor/thymidine phosphorylase overexpressing cells.
de Bruin M; Smid K; Laan AC; Noordhuis P; Fukushima M; Hoekman K; Pinedo HM; Peters GJ
Biochem Biophys Res Commun; 2003 Feb; 301(3):675-9. PubMed ID: 12565833
[TBL] [Abstract][Full Text] [Related]
15. Purification of thymidine phosphorylase from Escherichia coli and its photoinactivation in the presence of thymine, thymidine, and some halogenated analogs.
Voytek P
J Biol Chem; 1975 May; 250(10):3660-5. PubMed ID: 236298
[TBL] [Abstract][Full Text] [Related]
16. Blockage of 2-deoxy-D-ribose-induced angiogenesis with rapamycin counteracts a thymidine phosphorylase-based escape mechanism available for colon cancer under 5-fluorouracil therapy.
Seeliger H; Guba M; Koehl GE; Doenecke A; Steinbauer M; Bruns CJ; Wagner C; Frank E; Jauch KW; Geissler EK
Clin Cancer Res; 2004 Mar; 10(5):1843-52. PubMed ID: 15014039
[TBL] [Abstract][Full Text] [Related]
17. 5-Ethoxy-2'-deoxyuridine, a novel substrate for thymidine phosphorylase, potentiates the antitumor activity of 5-fluorouracil when used in combination with interferon, an inducer of thymidine phosphorylase expression.
Schwartz EL; Baptiste N; Megati S; Wadler S; Otter BA
Cancer Res; 1995 Aug; 55(16):3543-50. PubMed ID: 7627962
[TBL] [Abstract][Full Text] [Related]
18. Activity and substrate specificity of pyrimidine phosphorylases and their role in fluoropyrimidine sensitivity in colon cancer cell lines.
Temmink OH; de Bruin M; Turksma AW; Cricca S; Laan AC; Peters GJ
Int J Biochem Cell Biol; 2007; 39(3):565-75. PubMed ID: 17098463
[TBL] [Abstract][Full Text] [Related]
19. Thymidine esters as substrate analogue inhibitors of angiogenic enzyme thymidine phosphorylase in vitro.
Javaid S; Ishtiaq M; Shaikh M; Hameed A; Choudhary MI
Bioorg Chem; 2017 Feb; 70():44-56. PubMed ID: 27955923
[TBL] [Abstract][Full Text] [Related]
20. Determination of inorganic phosphate by coupling thymidine phosphorylase and reversed-phase high-performance liquid chromatography: application to tonoplast pyrophosphatase activity.
Hill M; Arrio B
Anal Biochem; 1997 Dec; 254(2):249-53. PubMed ID: 9417785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
